Application 020472
- Type
- NDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ESTRING | ESTRADIOL | INSERT, EXTENDED RELEASE;VAGINAL | 0.0075MG/24HR | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0013-2150 | Estring | estradiol | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0013-2150 | Estring | estradiol | Pharmacia and Upjohn Company LLC | NDA | Current |
| 0013-2150 | Estring | estradiol | Pharmacia and Upjohn Company LLC | NDA | Current |
| 63539-021 | Estring | estradiol | U.S. Pharmaceuticals | NDA | Current |
| 63539-021 | Estring | estradiol | U.S. Pharmaceuticals | NDA | Current |
| 63539-021 | Estring | estradiol | U.S. Pharmaceuticals | NDA | Current |
| 63539-021 | Estring | estradiol | U.S. Pharmaceuticals | NDA | Current |